Stock Events

Stock Events

EyePoint 

$13.75
32
-$0.1-0.72% Tuesday 20:00

Statistics

Day High
14.07
Day Low
13.32
52W High
18.85
52W Low
5.49
Volume
626,494
Avg. Volume
-
Mkt Cap
1.14B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.85
-0.73
-0.61
-0.49
Expected EPS
-0.805372
Actual EPS
N/A

Financials

-302.43%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
86.55MRevenue
-261.74MNet Income

Analyst Ratings

31.33Average Price Target
The highest estimate is 35.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EYPT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the ophthalmology space with treatments for eye diseases, directly competing with EyePoint's eye disease products.
Novartis
NVSEF
Mkt Cap279.92B
Novartis AG, through its acquisition of Alcon, offers a range of eye care products, including pharmaceuticals for chronic eye diseases, competing in the same market as EyePoint.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, after acquiring Allergan, has a strong presence in the eye care market, especially with products treating eye conditions like dry eye, directly competing with EyePoint's portfolio.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG, with its ophthalmology division, develops treatments for eye diseases such as macular degeneration, competing with EyePoint's disease-targeting treatments.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its eye health division, offers products for various eye conditions, competing in the same space as EyePoint Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its Vision Care division, provides products for eye health, including pharmaceuticals, competing with EyePoint's offerings.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. has a portfolio of ophthalmology drugs treating conditions like glaucoma, directly competing with EyePoint Pharmaceuticals in the eye care market.
Biogen
BIIB
Mkt Cap27.62B
Biogen Inc. has ventured into ophthalmology with treatments for eye diseases, representing a competitive presence in the market for EyePoint Pharmaceuticals.

About

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
Show more...
CEO
Dr. Jay S. Duker M.D.
Employees
165
Country
United States
ISIN
US30233G2093

Listings

MU
DE
PV3B.MU
STU
DE
PV3B.STU
F
DE
PV3B.F
XNAS
US
EYPT

0 Comments

Share your thoughts

FAQ

What is EyePoint stock price today?▼
The current price of EYPT is $13.75 USD — it has decreased by -0.72% in the past 24 hours. Watch EyePoint stock price performance more closely on the chart.
What is EyePoint stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange EyePoint stocks are traded under the ticker EYPT.
Is EyePoint stock price growing?▼
EYPT stock has risen by +6.92% compared to the previous week, the month change is a +4.88% rise, over the last year EyePoint has showed a +120% increase.
What is EyePoint market cap?▼
Today EyePoint has the market capitalization of 1.14B
What is EyePoint revenue for the last year?▼
EyePoint revenue for the last year amounts to 86.55M USD.
What is EyePoint net income for the last year?▼
EYPT net income for the last year is -261.74M USD.
How many employees does EyePoint have?▼
As of May 06, 2026, the company has 165 employees.
In which sector is EyePoint located?▼
EyePoint operates in the Health & Wellness sector.
When did EyePoint complete a stock split?▼
The last stock split for EyePoint was on December 09, 2020 with a ratio of 1:10.
Where is EyePoint headquartered?▼
EyePoint is headquartered in Watertown, United States.